
Flunarizine (10mg) + Propranolol (40mg)
Active composition
+1 more active ingredient
Flunarizine acts as a calcium channel blocker, preventing vasodilation and reducing the frequency of migraine attacks.
Propranolol blocks beta-1 and beta-2 adrenergic receptors, resulting in decreased heart rate, myocardial contractility, and overall cardiac output.
Medical applications
Mindpro-Plus Tablet SR is a controlled-release formulation containing a fixed combination of 40mg propranolol and 10mg flunarizine. This oral medication is indicated for the treatment of anxiety disorders, including generalized anxiety disorder and anxiety associated with depression. Propranolol, a beta-blocker, helps to reduce symptoms of anxiety and panic by blocking the actions of stress hormones, such as adrenaline. Flunarizine, a calcium channel blocker, contributes to the medication's anxiolytic and anti-inflammatory effects, while also exhibiting anticonvulsant and sedative properties. The sustained-release formulation of Mindpro-Plus Tablet SR allows for a gradual release of the active ingredients over a prolonged period, providing a prolonged duration of therapeutic effect. The medication is available in a tablet form with a SR coating, which ensures a controlled release of the active ingredients over a period of 12 hours. Mindpro-Plus Tablet SR is contraindicated in patients with known hypersensitivity to the active ingredients, and caution should be exercised in patients with a history of depression, heart failure, or chronic obstructive pulmonary disease.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Mindpro-Plus Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Information regarding the use of Mindpro-Plus Tablet SR during breastfeeding is not available. Please consult your doctor.
Medical Advice
Mindpro-Plus Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Mindpro-Plus Tablet SR may be needed. Please consult your doctor.
Exercise Caution
It is not known whether Mindpro-Plus Tablet SR alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
Mindpro-Plus Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Mindpro-Plus Tablet SR may be needed. Please consult your doctor. Regular monitoring of blood pressure is advisable for dose adjustment.
Regular Checkup
0 reviews for Mindpro-Plus Tablet SR

Propranolol (40mg) + Flunarizine (10mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Flunarizine acts as a calcium channel blocker, preventing vasodilation and reducing the frequency of migraine attacks.
Propranolol blocks beta-1 and beta-2 adrenergic receptors, resulting in decreased heart rate, myocardial contractility, and overall cardiac output.
Medical applications
Mindpro-Plus Tablet SR is a controlled-release formulation containing a fixed combination of 40mg propranolol and 10mg flunarizine. This oral medication is indicated for the treatment of anxiety disorders, including generalized anxiety disorder and anxiety associated with depression. Propranolol, a beta-blocker, helps to reduce symptoms of anxiety and panic by blocking the actions of stress hormones, such as adrenaline. Flunarizine, a calcium channel blocker, contributes to the medication's anxiolytic and anti-inflammatory effects, while also exhibiting anticonvulsant and sedative properties. The sustained-release formulation of Mindpro-Plus Tablet SR allows for a gradual release of the active ingredients over a prolonged period, providing a prolonged duration of therapeutic effect. The medication is available in a tablet form with a SR coating, which ensures a controlled release of the active ingredients over a period of 12 hours. Mindpro-Plus Tablet SR is contraindicated in patients with known hypersensitivity to the active ingredients, and caution should be exercised in patients with a history of depression, heart failure, or chronic obstructive pulmonary disease.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Mindpro-Plus Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Information regarding the use of Mindpro-Plus Tablet SR during breastfeeding is not available. Please consult your doctor.
Medical Advice
Mindpro-Plus Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Mindpro-Plus Tablet SR may be needed. Please consult your doctor.
Exercise Caution
It is not known whether Mindpro-Plus Tablet SR alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
Mindpro-Plus Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Mindpro-Plus Tablet SR may be needed. Please consult your doctor. Regular monitoring of blood pressure is advisable for dose adjustment.
Regular Checkup
0 reviews for Mindpro-Plus Tablet SR















